Concepedia

Marie Payton

MP

Statistics

Publications

2

Citations

111

H-Index

2

Active since

2017

Affiliations

Aileron (United States)(Current)

Montefiore Medical Center

Prisma Health

Albert Einstein College of Medicine

Sarah Cannon

Marie Payton is an author at Aileron (United States) specializing in tumor-targeting peptides, pharmacology, and p53 pathway inactivation.

Publications per year

2017–2018

2

Publications

2

Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of <i>WT p53</i> in patients with solid tumors and lymphomas.

Funda Meric‐Bernstam, Mansoor N. Saleh, Jeffrey R. Infante et al. · Journal of Clinical Oncology · 2017 · 79 citations

, , +16

Phase 1/1b Study of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, As Monotherapy or in Combination with Cytarabine for the Treatment of Relapsed/Refractory AML and Advanced MDS with TP53 Wild-Type

David A. Sallman, Uma Borate, Elizabeth H. Cull et al. · Blood · 2018 · 32 citations

, , +11

1–2 of 2